Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$246.67
-0.8%
$234.23
$145.87
$258.30
$57.49B0.511.70 million shs1.55 million shs
Cencora, Inc. stock logo
COR
Cencora
$330.52
-2.0%
$312.33
$244.82
$377.54
$63.15B0.571.26 million shs1.02 million shs
Eurofins Scient stock logo
ERFSF
Eurofins Scient
$85.93
-1.2%
$80.75
$64.95
$87.51
$16.29B0.571,336 shs1,474 shs
Humana Inc. stock logo
HUM
Humana
$400.70
-1.4%
$388.44
$163.11
$428.88
$48.22B0.741.01 million shs783,087 shs
The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
0.00%+5.09%+3.79%+19.87%+63.97%
Cencora, Inc. stock logo
COR
Cencora
0.00%+2.61%+1.69%+20.22%+12.11%
Eurofins Scient stock logo
ERFSF
Eurofins Scient
0.00%+4.48%+5.84%+13.09%+15.54%
Humana Inc. stock logo
HUM
Humana
0.00%+3.56%+8.89%+14.53%+28.34%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$246.67
-0.8%
$234.23
$145.87
$258.30
$57.49B0.511.70 million shs1.55 million shs
Cencora, Inc. stock logo
COR
Cencora
$330.52
-2.0%
$312.33
$244.82
$377.54
$63.15B0.571.26 million shs1.02 million shs
Eurofins Scient stock logo
ERFSF
Eurofins Scient
$85.93
-1.2%
$80.75
$64.95
$87.51
$16.29B0.571,336 shs1,474 shs
Humana Inc. stock logo
HUM
Humana
$400.70
-1.4%
$388.44
$163.11
$428.88
$48.22B0.741.01 million shs783,087 shs
The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
0.00%+5.09%+3.79%+19.87%+63.97%
Cencora, Inc. stock logo
COR
Cencora
0.00%+2.61%+1.69%+20.22%+12.11%
Eurofins Scient stock logo
ERFSF
Eurofins Scient
0.00%+4.48%+5.84%+13.09%+15.54%
Humana Inc. stock logo
HUM
Humana
0.00%+3.56%+8.89%+14.53%+28.34%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
2.84
Moderate Buy$266.568.06% Upside
Cencora, Inc. stock logo
COR
Cencora
2.81
Moderate Buy$370.8512.20% Upside
Eurofins Scient stock logo
ERFSF
Eurofins Scient
2.33
HoldN/AN/A
Humana Inc. stock logo
HUM
Humana
2.43
Hold$403.910.80% Upside

Current Analyst Ratings Breakdown

Latest ERFSF, COR, CAH, and HUM Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/4/2026
Humana Inc. stock logo
HUM
Humana
Reiterated RatingNeutral
8/24/2026
Humana Inc. stock logo
HUM
Humana
Reiterated RatingOutperform$450.00
8/19/2026
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
DowngradeBuy (B+)Buy (B)
8/19/2026
Cencora, Inc. stock logo
COR
Cencora
Initiated CoverageSector Perform$330.00
8/19/2026
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Initiated CoverageSector PerformOutperform$276.00
8/19/2026
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Initiated CoverageSector PerformOutperform$276.00
8/19/2026
Cencora, Inc. stock logo
COR
Cencora
Initiated CoverageSector Perform$330.00
8/14/2026
Humana Inc. stock logo
HUM
Humana
UpgradeHold (C-)Hold (C)
8/13/2026
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Boost Price TargetBuy$275.00 ➝ $280.00
8/13/2026
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Boost Price TargetOverweight$258.00 ➝ $275.00
8/13/2026
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Boost Price TargetNeutral$215.00 ➝ $260.00
(Data available from 9/6/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$254.25B0.23$15.44 per share15.98($11.71) per share-21.06
Cencora, Inc. stock logo
COR
Cencora
$638.56M98.77$21.59 per share15.31$16.97 per share19.48
Eurofins Scient stock logo
ERFSF
Eurofins Scient
$8.25B1.97$8.08 per share10.63$30.19 per share2.85
Humana Inc. stock logo
HUM
Humana
$129.66B0.37$24.01 per share16.69$160.53 per share2.50
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$1.71B$7.2334.1217.731.490.67%-98.53%4.69%10/29/2026 (Estimated)
Cencora, Inc. stock logo
COR
Cencora
$1.55B$13.4624.5616.721.880.79%125.45%4.18%11/4/2026 (Estimated)
Eurofins Scient stock logo
ERFSF
Eurofins Scient
$537.29MN/AN/AN/AN/AN/AN/AN/AN/A
Humana Inc. stock logo
HUM
Humana
$1.19B$10.5737.9126.262.630.88%11.20%3.94%11/6/2026 (Estimated)

Latest ERFSF, COR, CAH, and HUM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/11/2026Q4 2026
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$2.42$2.91+$0.49$1.70$65.15 billion$63.67 billion
8/5/2026Q3 2026
Cencora, Inc. stock logo
COR
Cencora
$4.35$4.48+$0.13$3.94$84.31 billion$84.75 billion
7/29/2026Q2 2026
Humana Inc. stock logo
HUM
Humana
$7.27$7.61+$0.34$5.73$40.58 billion$40.89 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$2.060.84%-4.74%28.49%29 Years
Cencora, Inc. stock logo
COR
Cencora
$2.400.73%+5.79%17.83%15 Years
Eurofins Scient stock logo
ERFSF
Eurofins Scient
N/AN/AN/AN/AN/A
Humana Inc. stock logo
HUM
Humana
$3.540.88%+7.20%33.49%N/A

Latest ERFSF, COR, CAH, and HUM Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
9/1/2026
Humana Inc. stock logo
HUM
Humana
quarterly$0.88500.88%10/30/202610/30/202611/27/2026
8/10/2026
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
quarterly$0.51580.86%10/1/202610/1/202610/15/2026
8/3/2026
Cencora, Inc. stock logo
COR
Cencora
quarterly$0.600.76%8/14/20268/14/20268/31/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
N/A
0.88
0.49
Cencora, Inc. stock logo
COR
Cencora
3.53
0.93
0.58
Eurofins Scient stock logo
ERFSF
Eurofins Scient
0.80
1.13
N/A
Humana Inc. stock logo
HUM
Humana
0.62
1.74
1.74

Institutional Ownership

CompanyInstitutional Ownership
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
87.17%
Cencora, Inc. stock logo
COR
Cencora
97.52%
Eurofins Scient stock logo
ERFSF
Eurofins Scient
N/A
Humana Inc. stock logo
HUM
Humana
92.38%

Insider Ownership

CompanyInsider Ownership
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
0.12%
Cencora, Inc. stock logo
COR
Cencora
0.38%
Eurofins Scient stock logo
ERFSF
Eurofins Scient
N/A
Humana Inc. stock logo
HUM
Humana
0.20%
CompanyEmployeesShares OutstandingFree FloatOptionable
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
63,900232.58 million232.30 millionOptionable
Cencora, Inc. stock logo
COR
Cencora
51,000190.83 million190.10 millionOptionable
Eurofins Scient stock logo
ERFSF
Eurofins Scient
62,696189.62 millionN/ANot Optionable
Humana Inc. stock logo
HUM
Humana
67,060120.08 million119.84 millionOptionable

Recent News About These Companies

Nykredit A S Purchases New Holdings in Humana Inc. $HUM
Van ECK Associates Corp Sells 8,739 Shares of Humana Inc. $HUM
3,146 Shares in Humana Inc. $HUM Bought by Retireful LLC
Braidwell LP Makes New Investment in Humana Inc. $HUM
Humana Inc. (NYSE:HUM) Announces $0.89 Quarterly Dividend
Analysts Set Humana Inc. (NYSE:HUM) PT at $403.91
Humana exit notices loom for 600,000 Medicare Advantage members
Humana (NYSE:HUM) Releases FY 2026 Earnings Guidance
Humana Reaffirms 2026 Earnings Guidance to Investors
Humana Foundation Names 2026 Scholarship Recipients

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Cardinal Health stock logo

Cardinal Health NYSE:CAH

$246.67 -1.94 (-0.78%)
As of 09/4/2026 03:58 PM Eastern

Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Cencora stock logo

Cencora NYSE:COR

$330.52 -6.70 (-1.99%)
As of 09/4/2026 03:58 PM Eastern

Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Eurofins Scient stock logo

Eurofins Scient OTCMKTS:ERFSF

$85.93 -1.00 (-1.15%)
As of 09/4/2026 03:32 PM Eastern

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agroscience, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, healthcare and cosmetics, and food supplements; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include sustainability, expert services and regulatory, consumer research and sensory evaluation, audits, testing, certifications and approvals, inspections, and training courses for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, training and consulting; food irradiation and labelling, heavy metals, carbohydrates, radioactivity, nutritional analysis, microbiolody, and testing for persistent organic pollutants, veterinary drug residue, dioxins and organic contaminants, pesticides, mycotoxins, and vitamins, as well as analyses for genetic modifications. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and other services. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.

Humana stock logo

Humana NYSE:HUM

$400.70 -5.82 (-1.43%)
As of 09/4/2026 03:58 PM Eastern

Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.